In Costly Cancer Drug, Hope and a Dilemma: Some Pay Up to $100,000 a Year for Avastin's Arguable Benefits
Creator
Kolata, Gina
Pollack, Andrew
Bibliographic Citation
New York Times 2008 July 6; p. A1, A16, A17
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Genentech Caps Cost of Cancer Drug for Some Patients
Pollack, Andrew (2006-10-12)